118 related articles for article (PubMed ID: 12529741)
1. Thrombin-induced hyperactivity of platelets of young stroke patients: involvement of thrombin receptors in the subject-dependent variability in Ca2+ signal generation.
Vanschoonbeek K; Feijge MA; Keuren JF; Coenraad Hemker H; Lodder JJ; Hamulyák K; van Pampus EC; Heemskerk JW
Thromb Haemost; 2002 Dec; 88(6):931-7. PubMed ID: 12529741
[TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca
Morikawa Y; Kato H; Kashiwagi H; Nishiura N; Akuta K; Honda S; Kanakura Y; Tomiyama Y
Thromb Res; 2018 Feb; 162():44-52. PubMed ID: 29289806
[TBL] [Abstract][Full Text] [Related]
3. Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity.
Dicker IB; Pedicord DL; Seiffert DA; Jamieson GA; Greco NJ
Thromb Haemost; 2001 Oct; 86(4):1065-9. PubMed ID: 11686325
[TBL] [Abstract][Full Text] [Related]
4. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
[TBL] [Abstract][Full Text] [Related]
5. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk.
van der Meijden PE; Feijge MA; Giesen PL; Huijberts M; van Raak LP; Heemskerk JW
Thromb Haemost; 2005 Jun; 93(6):1128-36. PubMed ID: 15968399
[TBL] [Abstract][Full Text] [Related]
6. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
7. Platelets in patients with acute ischemic stroke are exhausted and refractory to thrombin, due to cleavage of the seven-transmembrane thrombin receptor (PAR-1).
Jurk K; Jahn UR; Van Aken H; Schriek C; Droste DW; Ritter MA; Bernd Ringelstein E; Kehrel BE
Thromb Haemost; 2004 Feb; 91(2):334-44. PubMed ID: 14961162
[TBL] [Abstract][Full Text] [Related]
8. PKC inhibition markedly enhances Ca2+ signaling and phosphatidylserine exposure downstream of protease-activated receptor-1 but not protease-activated receptor-4 in human platelets.
Harper MT; Poole AW
J Thromb Haemost; 2011 Aug; 9(8):1599-607. PubMed ID: 21649850
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of Ca2+ movement in platelets from patients with acute ischaemic stroke.
Tsai NW; Lu CH; Chang WN; Shaw CF; Huang CR; Chen SD; Chuang YC; Lee LH; Jan CR
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):380-5. PubMed ID: 19018807
[TBL] [Abstract][Full Text] [Related]
10. Residual thrombin generation potential is inversely linked to the occurrence of atherothrombotic events in patients with peripheral arterial disease.
Gremmel T; Koppensteiner R; Ay C; Panzer S
Eur J Clin Invest; 2014; 44(3):319-24. PubMed ID: 24382127
[TBL] [Abstract][Full Text] [Related]
11. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
12. Systems biology insights into the meaning of the platelet's dual-receptor thrombin signaling.
Sveshnikova AN; Balatskiy AV; Demianova AS; Shepelyuk TO; Shakhidzhanov SS; Balatskaya MN; Pichugin AV; Ataullakhanov FI; Panteleev MA
J Thromb Haemost; 2016 Oct; 14(10):2045-2057. PubMed ID: 27513817
[TBL] [Abstract][Full Text] [Related]
13. YD-3, a novel inhibitor of protease-induced platelet activation.
Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1.
Keuren JF; Wielders SJ; Ulrichts H; Hackeng T; Heemskerk JW; Deckmyn H; Bevers EM; Lindhout T
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1499-505. PubMed ID: 15845904
[TBL] [Abstract][Full Text] [Related]
15. Platelet responses to compound interactions with thrombin.
Smith RD; Owen WG
Biochemistry; 1999 Jul; 38(28):8936-47. PubMed ID: 10413467
[TBL] [Abstract][Full Text] [Related]
16. Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition.
Badr Eslam R; Lang IM; Kaider A; Panzer S
Transl Res; 2013 May; 161(5):414-20. PubMed ID: 23313628
[TBL] [Abstract][Full Text] [Related]
17. The role of PAR4 in thrombin-induced thromboxane production in human platelets.
Wu CC; Hwang TL; Liao CH; Kuo SC; Lee FY; Teng CM
Thromb Haemost; 2003 Aug; 90(2):299-308. PubMed ID: 12888878
[TBL] [Abstract][Full Text] [Related]
18. The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1.
Poullis M; Manning R; Laffan M; Haskard DO; Taylor KM; Landis RC
J Thorac Cardiovasc Surg; 2000 Aug; 120(2):370-8. PubMed ID: 10917956
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
20. Increased responsiveness to thrombin through protease-activated receptors (PAR)-1 and -4 in active Crohn's disease.
Schmid W; Vogelsang H; Papay P; Primas C; Eser A; Gratzer C; Handler M; Novacek G; Panzer S
J Crohns Colitis; 2014 Jun; 8(6):495-503. PubMed ID: 24291018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
